A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.


Updates from The Motley Fool

Latest updates on NxStage Medical from Fool.com.
NxStage Medical Appoints New CFO

The finance team at NxStage Medical (NASDAQ: NXTM) has a new leader. The company announced it...



Stock Performance

View Interactive NXTM Charts
Sponsored by

Key Data Points

Primary metrics and data points about NxStage Medical.
Current Price: $23.93
Prev Close: $23.94
Open: $23.93
Bid: $23.72
Ask: $28.00
Day's Range: $23.80 - $24.09
52wk Range: $13.49 - $26.83
Volume: 248,507
Avg Vol 462,534
Market Cap: $2B
P/E (ttm): -266.00
EPS (ttm): ($0.09)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about NxStage Medical.
CAPS Rating 3 out of 5
 
145 Outperform
33 Underperform
CAPS All Stars
 
34 Outperform
7 Underperform

How do you think NxStage Medical will perform against the market?



You pick for NxStage Medical is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Jeff Burbank, CEO

98% Approve

Based on 20 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for NxStage Medical.

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT